- Mathew TC, Vasudevan R, Leb L et al. Coronary artery bypass grafting in immune thrombocytopenic purpura. Ann ThoracSurg 1997; 64: 1059-1062.
- Fuchi T, Kondo T, Sase K et al. Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. Jpn Circ J 1999; 63: 133-136.
- Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRlSC 11 invasive randomised trial. FRlSC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Eancet 2000; 356: 9-16.
- Eandl JH. Blood-Textbook of Haematology. 2nd ed. Boston, MA Little, Brown and Co, 1996: 1311.
- The EPlSTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronaiy stenting with use of platelet glycoprotein- lib/Ilia blockade. Evaluation of Platelet lib/Ilia Inhibitor for Stenting. Lancet 1998; 352: 87-92.
- Muller C, Buttner HJ, Petersen J et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000; 101: 590-593.
- Bennett CL, Connors JM, Carwile JM et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000; 342: 1773-1777.
- Jordan RE, Wagner CL, Mascaill MA et al. Preclinical development of c7E3 Fab; a mouse/human chimeric monoclonal antibody fragment that inhibits platelet function by blockade of GPllb/Illa receptors with observations on the immunogenicity of c7E3 Fab in humans. In: Horton MA, ed. Adhesion Receptors as Therapeutic Targets. Boca Raton, Fl CRC Press, 1996:281-302.
- Casterella Kereiakes DJ, Steinhubl SR et al. J Am Coll Cardiol 1999;33(Suppl A): 39A. Use of rapid platelet function analysis (RPFA) to evaluate platelet function in patients receiving incremental bolus dosing of abciximab during percutaneous coronaiy intervention (PCl).
Percutaneous coronary intervention with adjunctive abciximab and clopidogrel in a patient with chronic idiopathic thrombocytopaenic purpura
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.